ArticleBioorganic & medicinal chemistry letters2021

Discovery of spirohydantoins as selective, orally bioavailable inhibitors of p300/CBP histone acetyltransferases.

Zhiqin Ji et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.